Text Size

Description and Evaluation of Eating Disorders in Elite Athletes (TCA SHN)

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT01544400
First received: February 17, 2012
Last updated: March 22, 2013
Last verified: March 2013
History of Changes
  Purpose

Athletes in particular elite athletes have obsessional food and body concerns, in bond with a worship of the performance more and more invading, which lead to clinical and subclinical eating disorders. These eating disorders differ according to the disciplines and are difficult to diagnose in athletes because there are insufficiently described.

Our aim at estimating the frequency of eating disorders in athletes and describing eating disorders by means of somatic, dietetic and psychological evaluations.


Condition
Eating Disorders
Anorexia Nervosa
Boulimia Nervosa
Binge Eating Disorders

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Description and Evaluation of Eating Disorders in Elite Athletes

Resource links provided by NLM:

MedlinePlus related topics: Eating Disorders
U.S. FDA Resources

Further study details as provided by Nantes University Hospital:

Primary Outcome Measures:
  • Presence of eating disorder [ Time Frame: 1 day ] [ Designated as safety issue: No ]

    A subject presents an eating disorder if at least one of the tree clinical investigators (somatician, dietician, psychologist) mark it.

    Eating disorders will be described by:

    Dietetic consultation, Somatic examination, Psychological evaluation



Secondary Outcome Measures:
  • Presence of eating disorder according to the psychologist, dietician and the somatician [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    Presence of eating disorder according to the psychologist, dietician and the somatician

  • Sociodemographic variables [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    age, sex, sporting discipline exercised

  • Doping conduits variables [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    age of onset of consumption (PAP support products performance) legal and illegal, current frequency of consumption of PAP licit and illicit consumption as problematic or not the patient.

  • Investment in practice sporting variables [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    Desired level of sports, number of hours per week over the last 4 weeks, up / concern of the sport.

  • Addictives and psychiatric comorbidity [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    anxiety disorders, depression and sleep disorders Scale : GEEMS, EDI, EDS-R


Enrollment: 386
Study Start Date: June 2010
Study Completion Date: January 2013
Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Athletes registered on the high level sportsmen list or in access to high level sport

Criteria

Inclusion Criteria:

  • to have at least 12 years
  • to be registered on the high level sportsmen list or to be in access to high level sport
  • to have obtained the non opposition of the athlete if he is major (if not the legal person in charge of the athlete have to give is non opposition).
  • to be affiliated to social security

Exclusion Criteria:

  • presenting obvious cognitive disturbance
  • not able to understand or/ and to read French language
  • pregnant women
  • subject under tutelage
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01544400

Locations
France
Prétagut
CHU Nantes, France, 44000
Sponsors and Collaborators
Nantes University Hospital
Investigators
Principal Investigator: Stephane Pretagut CHU de Nantes
Principal Investigator: Serge Lise University Hospital, Bordeaux
Principal Investigator: Michel GUINOT University Hospital, Grenoble
  More Information

No publications provided

Responsible Party: Nantes University Hospital
ClinicalTrials.gov Identifier: NCT01544400     History of Changes
Other Study ID Numbers: 09/03-V
Study First Received: February 17, 2012
Last Updated: March 22, 2013
Health Authority: France : AFSSAPS

Keywords provided by Nantes University Hospital:
reverse anorexia,
anorexia athletics

Additional relevant MeSH terms:
Anorexia
Anorexia Nervosa
Bulimia
Binge-Eating Disorder
Eating Disorders
 Bulimia Nervosa
Signs and Symptoms, Digestive
Signs and Symptoms
Mental Disorders
Hyperphagia

ClinicalTrials.gov processed this record on May 19, 2013